RL
Relief Therapeutics
RLF.SW·SIXGeneva CHFounded 201620 employees
Micro CapbiotechPublicRespiratoryRare Disease
Platform: Sentinox NO
Market Cap
$0.03B
All Drugs
2
Clinical Trials
6
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (RLF.SW)
Loading RLF.SW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RLF-2389 | RLF-2389 | Approved | 3 | CD3 | Ovarian CaAtopic Derm | ||
| RLF-5973 | RLF-5973 | Phase 3 | 3 | C5 | Breast Ca |
SEC Filings & Financial Documents
SEC filings are not available for SIX-listed companies.
Relief Therapeutics trades on SIX (CH). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)